Hinge Health, Inc.
NYSE:HNGE · New York Stock Exchange
-$0.24 today
Vol 2.83M · Avg 1.34M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+58.89%
Period High
$69.42
Period Low
$31.17
Latest
$69.42
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Oscar Health, Inc.
NYSE:OSCR
$7.30B
Immunovant, Inc.
NASDAQ:IMVT
$7.25B
Lantheus Holdings, Inc.
NASDAQ:LNTH
$6.79B
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
$5.95B
Indivior Pharmaceuticals Inc
NASDAQ:INDV
$4.77B
Akero Therapeutics, Inc.
AKRO
$4.50B
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
$3.77B
Viking Therapeutics, Inc.
NASDAQ:VKTX
$3.62B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.27B
GeneDx Holdings Corp.
NASDAQ:WGS
$1.69B
What is the latest HNGE filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does HNGE have?
Intrinsic Alpha currently shows 20 recent filings for HNGE.
Explore More
Continue the stock analysis
Jump to another research area for this company.